Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

BioNTech SE

BNTX · Nasdaq · CIK 0001776985 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

27 Form 4 transaction lines observed in the same window
27 sales · 0 option, withholding, award, gift or other lines

Last qualifying purchaseNo qualifying purchase is present in the local Form 4 history.

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Sahin UgurChief Executive Officer
▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼
Poetting SierkChief Operating Officer
▼
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot.—

Recent Form 4 activity

0Purchases
27Sales
0Other Form 4 lines
15SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING27 sale line(s) · context only
OTHER0 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
2,496,813
Previous report
2,322,764
Avg daily volume
799,043
Days to cover
3.1

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

No qualifying code P equity purchase is present in the local Form 4 history.

Form 4 evidence

27 transaction lines in the latest 365-day window; 27 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-09Sahin UgurSale (S)Ordinary Shares36,209USD 95.37USD 3,453,372SEC filing ↗
2026-10-08Sahin UgurSale (S)Ordinary Shares27,000USD 92.31USD 2,492,483SEC filing ↗
2026-10-07Sahin UgurSale (S)Ordinary Shares24,000USD 95.86USD 2,300,633SEC filing ↗
Show recent Form 4 evidence (27 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-09Sahin UgurSale (S)Ordinary Shares36,209USD 95.37USD 3,453,372SEC filing ↗
2026-10-08Sahin UgurSale (S)Ordinary Shares27,000USD 92.31USD 2,492,483SEC filing ↗
2026-10-07Sahin UgurSale (S)Ordinary Shares24,000USD 95.86USD 2,300,633SEC filing ↗
2026-10-06Sahin UgurSale (S)Ordinary Shares21,000USD 96.81USD 2,032,995SEC filing ↗
2026-10-05Sahin UgurSale (S)Ordinary Shares72,000USD 97.23USD 7,000,646SEC filing ↗
2026-10-02Sahin UgurSale (S)Ordinary Shares17,000USD 96.72USD 1,644,323SEC filing ↗
2026-10-01Sahin UgurSale (S)Ordinary Shares17,000USD 97.46USD 1,656,745SEC filing ↗
2026-09-30Sahin UgurSale (S)Ordinary Shares32,000USD 98.12USD 3,139,840SEC filing ↗
2026-09-29Sahin UgurSale (S)Ordinary Shares34,000USD 98.26USD 3,340,840SEC filing ↗
2026-09-28Sahin UgurSale (S)Ordinary Shares34,000USD 98.47USD 3,347,980SEC filing ↗
2026-09-25Sahin UgurSale (S)Ordinary Shares27,000USD 98.69USD 2,664,630SEC filing ↗
2026-09-24Sahin UgurSale (S)Ordinary Shares39,000USD 98.99USD 3,860,610SEC filing ↗
2026-09-23Sahin UgurSale (S)Ordinary Shares30,000USD 99.40USD 2,982,000SEC filing ↗
2026-09-22Sahin UgurSale (S)Ordinary Shares46,000USD 100.72USD 4,633,120SEC filing ↗
2026-09-21Sahin UgurSale (S)Ordinary Shares33,000USD 97.81USD 3,227,730SEC filing ↗
2026-09-18Sahin UgurSale (S)Ordinary Shares30,000USD 96.22USD 2,886,600SEC filing ↗
2026-09-17Sahin UgurSale (S)Ordinary Shares34,000USD 98.60USD 3,352,400SEC filing ↗
2026-09-16Sahin UgurSale (S)Ordinary Shares15,000USD 96.09USD 1,441,350SEC filing ↗
2026-09-15Sahin UgurSale (S)Ordinary Shares34,000USD 96.49USD 3,280,660SEC filing ↗
2026-09-14Sahin UgurSale (S)Ordinary Shares41,000USD 99.45USD 4,077,450SEC filing ↗
2026-09-11Sahin UgurSale (S)Ordinary Shares45,000USD 96.93USD 4,361,850SEC filing ↗
2026-09-10Sahin UgurSale (S)Ordinary Shares20,500USD 96.31USD 1,974,355SEC filing ↗
2026-09-09Sahin UgurSale (S)Ordinary Shares36,000USD 97.78USD 3,520,080SEC filing ↗
2026-09-08Sahin UgurSale (S)Ordinary Shares37,000USD 99.20USD 3,670,400SEC filing ↗
2026-09-04Sahin UgurSale (S)Ordinary Shares31,500USD 103.52USD 3,260,880SEC filing ↗
2026-09-03Sahin UgurSale (S)Ordinary Shares45,000USD 102.85USD 4,628,250SEC filing ↗
2026-04-22Poetting SierkSale (S)Ordinary Shares50,000USD 110.56USD 5,528,000SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerBNTX
CIK0001776985
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNasdaq

Data coverage

Local Form 4 history27 transaction lines from 2026-04-22 to 2026-10-09
0 P purchase lines · 27 S sale lines · 0 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.